Search results
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 4 days agoThe US Food and Drug Administration’s committee of independent advisers voted unanimously Wednesday...
Experimental mRNA vaccines gain steam with promising cancer trial results
Semafor via Yahoo News· 6 days agoAfrica, Senegal and Tunisia to target diseases such as tuberculosis, rift valley fever and...
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
CNBC· 7 days agoThe vaccine together with Merck's Keytruda improved survival and showed long-lasting efficacy in a...
Here’s what a Nobel Prize-winning scientist wants you to know about the Covid-19 vaccines and the...
CNN via Yahoo News· 5 days agoIn his new book “The Catalyst,” Thomas R. Cech talks about the Covid-19 vaccines, what RNA means for...
Moderna Files FDA Application for the JN.1 Targeting COVID-19 Vaccine
Morningstar· 3 days agoManufacturing is underway and doses of Moderna's Spikevax 2024-2025 formula will be ready to ship as early as August, pending regulatory approval CAMBRIDGE ...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 4 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA ...
ASCO: After Keytruda, Merck builds 3-pronged cancer strategy starring Moderna-partnered vaccine
FierceBiotech· 7 days agoAs Keytruda’s 2028 patent cliff looms large, Merck & Co.’s renewed R&D oncology strategy focuses on...
Analysis | Four questions for today’s Fauci hearing
Washington Post· 7 days agoThe Texas Supreme Court rejected a lawsuit that sought to clarify exceptions to the state’s abortion laws. The longtime infectious-disease expert is back...
A shot in the arm that can help fight cancer? How vaccine trials are showing promise.
USA TODAY via Yahoo News· 5 days agoShe's currently testing a KRAS-targeted vaccine in people at high risk for pancreatic cancer. Her...
Edwards Lifesciences Stock Jumps On Surprise $4.2 Billion Deal
Investor's Business Daily· 6 days agoEdwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key...